Mahesh Swaminathan
Overview
Explore the profile of Mahesh Swaminathan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
940
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
DiNardo C, Jen W, Takahashi K, Kadia T, Loghavi S, Daver N, et al.
Leukemia
. 2025 Feb;
PMID: 40000842
Intensive chemotherapy remains the standard for newly diagnosed (ND) acute myeloid leukemia (AML); however, relapse risk remains high. Additionally, most patients with relapsed/refractory (RR) AML have poor outcomes. We report...
2.
Senapati J, Loghavi S, Marvin-Peek J, Garcia-Manero G, Kadia T, Borthakur G, et al.
Am J Hematol
. 2025 Feb;
PMID: 39921561
Ontogeny of acute myeloid leukemia (AML) provides prognostic information, however closer interrogation with respect to AML characteristics, genomics, and various treatments are warranted. We defined untreated clinical secondary (CS) AML...
3.
Jen W, Marvin-Peek J, Kantarjian H, Alvarado Y, Borthakur G, Jabbour E, et al.
Cancer
. 2024 Nov;
131(1):e35662.
PMID: 39584789
Background: All-trans retinoic acid (ATRA) and arsenic trioxide (ATO) combinations have produced excellent outcomes in patients with standard-risk acute promyelocytic leukemia (APL). Herein, the authors update their long-term results with...
4.
Chien K, Rodriguez-Sevilla J, Alvarado Y, Montalban-Bravo G, Hammond D, Swaminathan M, et al.
Leuk Res
. 2024 Oct;
147:107602.
PMID: 39461095
No abstract available.
5.
Singh A, Trinchant N, Mishra R, Arora K, Mehta S, Kuzmanovic T, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456832
Cancer cohorts are now known to be associated with increased rates of clonal hematopoiesis (CH). We sort to characterize the hematopoietic compartment of patients with melanoma and non-small cell lung...
6.
Swaminathan M, Jain A, Choi S, Pemmaraju N
Expert Rev Hematol
. 2024 Sep;
17(11):769-780.
PMID: 39344987
Introduction: JAK inhibitors (JAKi) have changed the treatment paradigm of myelofibrosis (MF). Currently, 4 JAKis are approved in the US as monotherapy (mono) to treat patients with MF. JAKis are...
7.
Blackburn D, Mba N, Nwachukwu W, Zhou H, Hill A, Abbott A, et al.
Am J Trop Med Hyg
. 2024 Sep;
111(5):1005-1014.
PMID: 39255809
Congenital transmission of Toxoplasma gondii can occur when a woman becomes infected for the first time during or just before pregnancy. Toxoplasma gondii in the fetus can lead to miscarriage,...
8.
Mmbaga V, Mrema G, Ngenzi D, Magoge W, Mwakapasa E, Jacob F, et al.
PLoS One
. 2024 Sep;
19(9):e0309762.
PMID: 39236024
Introduction: In March 2023, a Marburg Virus Disease (MVD) outbreak was declared in Kagera region, Northwestern Tanzania. This was the first MVD outbreak in the country. We describe the epidemiological...
9.
Marvin-Peek J, Shelton V, Brassil K, Fellman B, Barr A, Chien K, et al.
Acta Haematol
. 2024 Jun;
:1-10.
PMID: 38861934
Introduction: Promotion of self-efficacy can enhance engagement with health care and treatment adherence in patients with cancer. We report the outcomes of a pilot trial of a digital health coach...
10.
Hussein A, Kishimba R, Simba A, Urio L, Lema N, Mmbaga V, et al.
PLOS Glob Public Health
. 2024 May;
4(5):e0003189.
PMID: 38809954
Viral Haemorrhagic Fever Outbreak presents a significant public health threat, requiring a timely, robust, and well-coordinated response. This paper aims to describe the roles of the Tanzania Field Epidemiology and...